Dergiler / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2022 / Cilt: 35 - Sayı: 1

The use of methamphetamine in the probation population

Sayfa
2–12
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, a probation program might provide an opportunity to raise awareness of substance-related medical and social problems and to motivate individuals who are relatively less engaged with treatment to initiate a therapeutic process.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Our research aimed to determine the frequency of methamphetamine use among people referred to health institutions for treatment with the probation decision and to reveal the sociodemographic and clinical profile of people who use methamphetamine.
📊
Temel Bulgular & Veri:Method: Four hundred and forty-two consecutive cases between 18 and 65 years of age who were referred for treatment to the Probation Outpatient Clinic in Bakirkoy Prof.
💡
Sonuç & Katkı:In addition, a probation program might provide an opportunity to raise awareness of substance-related medical and social problems and to motivate individuals who are relatively less engaged with treatment to initiate a therapeutic process.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Our research aimed to determine the frequency of methamphetamine use among people referred to health institutions for treatment with the probation decision and to reveal the sociodemographic and clinical profile of people who use methamphetamine. Method: Four hundred and forty-two consecutive cases between 18 and 65 years of age who were referred for treatment to the Probation Outpatient Clinic in Bakirkoy Prof. Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery were included in the study. Sociodemographic and clinical information of the cases, substance use and treatment histories, and criminal histories were recorded and evaluated with a semi-structured form. Urine toxicology results, which were taken as one of the obligations of the probation treatment program, were examined. Results: Substance metabolites were detected in the urine toxicological analysis of 81% of the cases. Methamphetamine use was detected in 24.4% of the sample. It was the second most common illicit substance after cannabis and the fourth common seized. Inhalation was the most common method of methamphetamine use. Of the cases still using methamphetamine, 90.7% (n=98) were found to use at least one substance other than methamphetamine. Emergency admissions for substance-related problems, inpatient addiction treatment, outpatient psychiatric treatment, and forensic histories were significantly higher in the group with methamphetamine use than in the group without methamphetamine use. Conclusion: Our study is the first to evaluate the rate of methamphetamine use in the probation population and the sociodemographic and clinical profile of people with methamphetamine use. According to the data obtained, one-fourth of the probation population was using methamphetamine. This group represented a more criminally engaged subgroup of substance users with more inpatient addiction treatment and outpatient psychiatric treatment needs with a high rate of polysubstance use. Recognizing the profile of methamphetamine users is essential to develop strategies to meet their treatment needs. In addition, a probation program might provide an opportunity to raise awareness of substance-related medical and social problems and to motivate individuals who are relatively less engaged with treatment to initiate a therapeutic process.

🔖

Bu Makaleye Atıf Yap

ALNIAK, İ., ULUSOY, S., CEBECİ, B. A. (2022). The use of methamphetamine in the probation population. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 35 - Sayı: 1, 2–12. https://ajindex.com/articles/493706

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Turkish Penal Code, https://www.mevzuat.gov.tr/ MevzuatMetin/1.5.5237.pdf. Accessed March 17, 2022. [Turkish] 2. Oncu F, Can FY. The practical reflection of alcohol and substance use disorder in judicial processes. In: Basic Reference Book on Alcohol and Substance Use Disorders. Evren C (editor). Istanbul: Turkish Psychiatric Association Study Units Series 24, 2019. [Turkish] 3. Webster JM, Dickson MF, Saman DM, Mateyoke-Scrivner A, Oser CB, Leukefeld C. Substance use, criminal activity, and mental health among violent and nonviolent rural probationers. J Addict Offender Couns 2010
  2. 99–111. 4. Yazici AB, Yazici E, Kumsar NA, Erol A. Addiction profile in probation practices in Turkey: 5-year data analysis. Neuropsychiatr Dis Treat 2015
  3. 2259–2263. 5. Mutlu E, Alniak I, Aksoy UM, Erkiran M. The use of synthetic cannabinoids among probation population. J Forensic Med 2015
  4. 169–178. 6. European Drug Report 2021: Trends and developments. https://www.emcdda.europa.eu/publications/edr/trendsdevelopments/ 2021_en. Accessed March 17, 2022. 7. World Drug Report 2021. https://www.unodc.org/unodc/en/ data-and-analysis/wdr2021.html 8. Turkish Drug Report 2021: Trends and developments. http:// www.narkotik.pol.tr/kurumlar/narkotik.pol.tr/TUBİM/2021- TURKISH-DRUG-REPORT.pdf. Accessed March 17, 2022. 9. Kohno M, Beste C, Pilhatsch M. Editorial: The global methamphetamine problem: approaches to elucidate the neurobiology, epidemiology, and therapeutic effectiveness. Front Psychiatry 2020
  5. Chen T, Spiller HA, Badeti J, Funk AR, Zhu M, Smith GA. Methamphetamine exposures reported to United States poison control centers, 2000-2019. Clin Toxicol (Phila) 2021
  6. 705– 714. 11. Chiang M, Lombardi D, Du J, Makrum U, Sitthichai R, Harrington A, et al. Methamphetamine-associated psychosis: clinical presentation, biological basis, and treatment options. Hum Psychopharmacol 2019
  7. e2710. 12. Vivolo-Kantor AM, Hoots BE, Seth P, Jones CM. Recent trends and associated factors of amphetamine-type stimulant overdoses in emergency departments. Drug Alcohol Depend 2020
  8. 108323. 13. European Drug Report 2019: Trends and developments. https://www.emcdda.europa.eu/publications/edr/trendsdevelopments/ 2019_en. Accessed March 17, 2022. 14. Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The opioid epidemic in the United States. Emerg Med Clin North Am 2016
  9. e1–e23. 15. Guy Jr GP, Zhang K, Bohm MK, Losby J, Lewis B, Young R, et al. Vital signs: changes in opioid p